Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2025 ,inter alia, to consider and approve the audited financial results ....

Net loss reportedEBITDA margin compressionNegative operating cash flowDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.0%Reaction day

₹15.88

prior close

₹15.89

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-3.8% vs market

Other Agricultural Products peers, median of 56sector+0.5%-3.5% vs sector

On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.5 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-2.5

15m

+0.0

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.0+0.7-3.8+0.5-3.5

Next day

-3.0+1.2-4.2+0.3-3.4

-5.5-0.3-5.2-0.8-4.8

-2.7-0.7-2.0-1.5-1.2

-5.5-0.4-5.2-0.8-4.7

-4.3-1.4-2.9-1.8-2.5

-10.1-3.4-6.7-4.8-5.3

15d

-4.0+0.9-4.9-0.9-3.1

-1.8+1.5-3.3-1.9+0.1

-14.0-3.6-10.4-6.5-7.6

-21.9-0.8-21.1-5.0-16.9

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 56Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indrayani Biotech has postponed its Board meeting from 9th June 2025 to 12th June 2025 to consider and approve its audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025. The company had already missed the SEBI-mandated deadline of 30th May 2025 under Regulation 33 of the LODR. According to the filing, the delay is due to the consolidation of results from its subsidiaries and the completion of internal and external audit processes taking longer than expected. The Board meeting that was held on 9th June was adjourned after running from 4:00 PM to 8:00 PM. The trading window for designated persons remains closed until 48 hours after the results are declared.

Likely market impact

This is a regulatory compliance delay and does not directly affect shareholder value, but repeated postponements of financial results may dent investor confidence and signal operational or accounting complexities within the company's subsidiaries. Retail investors should await the results on 12th June for clarity on actual financials.

By the numbersConsolidated · Q4 FY25 vs Q4 FY24

	Q4 FY25	Q4 FY24	Change
Revenue	₹50.57 Cr	₹44.38 Cr	+13.9%
Operating profit	−₹11.10 Cr	₹3.70 Cr	−399.9%
Profit after tax	−₹8.53 Cr	₹4.73 Cr	−280.1%
EBITDA margin	-11.3%	22.9%	−34.3 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.